SCHEDULE: Morgan Stanley Reduces Cryoport Stake Below 5%

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amendment to their Schedule 13G, reporting a beneficial ownership of Cryoport, Inc. common stock below the 5% threshold.

Summary

• Morgan Stanley and Morgan Stanley Capital Services LLC have filed an amendment to their Schedule 13G filing for Cryoport, Inc.
• The filing indicates that both entities have ceased to be beneficial owners of more than five percent of Cryoport, Inc.'s common stock.
• Morgan Stanley now beneficially owns 2,246,650 shares, representing 4.5% of the class of securities.
• Morgan Stanley Capital Services LLC beneficially owns 2,163,384 shares, representing 4.3% of the class of securities.
• The filing is dated June 30, 2026, with the signatures dated August 13, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral to slightly negative filing, primarily due to the reporting entities indicating they have ceased to be beneficial owners of more than five percent of the class of securities, suggesting a divestment or reduction in holdings.

Negatives

• Morgan Stanley and Morgan Stanley Capital Services LLC have reduced their beneficial ownership below the 5% threshold, indicating a decrease in their stake in Cryoport, Inc.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future performance.

Management Comments

• As of the date hereof, Morgan Stanley has ceased to be the beneficial owner of more than five percent of the class of securities.
• As of the date hereof, Morgan Stanley Capital Services LLC has ceased to be the beneficial owner of more than five percent of the class of securities.
• In accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by certain operating units (collectively, the "MS Reporting Units") of Morgan Stanley and its subsidiaries and affiliates (collectively, "MS"). This filing does not reflect securities, if any, beneficially owned by any operating units of MS whose ownership of securities is disaggregated from that of the MS Reporting Units in accordance with the Release.

Industry Context

StockSavvy.ai notes that a reduction in holdings by a significant institutional investor like Morgan Stanley, even if it falls just below the 5% reporting threshold, can sometimes be interpreted by the market as a signal of reduced conviction or a shift in strategy, though the exact reasons are not disclosed.

Stakeholder Impact

• Shareholders may view the reduction in holdings by Morgan Stanley as a potential indicator of decreased institutional confidence, which could influence market sentiment.

Key Dates

Recommendation

The filing indicates a reduction in beneficial ownership by Morgan Stanley below the 5% threshold. While this suggests a decrease in their stake, it does not provide enough information to warrant a strong buy or sell recommendation. The reduction could be for various reasons, including portfolio rebalancing, and the remaining stake is still significant. Therefore, a 'hold' recommendation is appropriate pending further information or market reaction.

Keywords

Cryoport, Morgan Stanley, Schedule 13G, beneficial ownership, stock, securities